
AD Burden on Patients
AD Burden on Patients
Learn more
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.


AD Burden on Patients

Once diagnosed with stage 3 aT1D, patients require lifelong exogenous insulin. This significantly impacts activities of daily living and quality of life, particularly during childhood and adolescence.1-3
.jpg)





